Welcome Prof. Vuanghao Lim as Co-Editor-in-Chief of ACPT

We are delighted to welcome Prof. Vuanghao Lim as Co-Editor-in-Chief of Advances in Clinical Pharmacology and Therapeutics (ACPT).

His research focuses on natural products drug discovery, nanodrug carrier synthesis, and metabolomics/chemometrics. He has published extensively in high-impact journals, including International Journal of Nanomedicine, Drug Delivery and Translational Research, Food Chemistry, and Industrial Crops and Products, covering topics such as metabolomics-driven bioactive compound identification, redox-responsive polymeric nanocarriers, and nanoparticle-based therapeutics.

Prof. Lim is listed among the World’s Top 2% Scientists by Stanford University (2024, 2025). He is a Professional Technologist registered with the Malaysia Board of Technologists, a member of the American Chemical Society and Malaysia Local Chapter of the Controlled Release Society, and serves as an editorial board member for several international journals. He has been invited as a keynote and plenary speaker at numerous international conferences, and has served as a visiting professor and external examiner for universities across Asia, Australia, and Europe.

Prof. Lim’s expertise in pharmaceutical sciences, nanotechnology, and metabolomics will greatly strengthen the journal’s scope and international standing. We look forward to his contributions and guidance in shaping the future of ACPT.